Welcome to LookChem.com Sign In|Join Free
  • or
Benzene, [(9-decenyloxy)methyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

100189-71-7

Post Buying Request

100189-71-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100189-71-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 100189-71-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,1,8 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 100189-71:
(8*1)+(7*0)+(6*0)+(5*1)+(4*8)+(3*9)+(2*7)+(1*1)=87
87 % 10 = 7
So 100189-71-7 is a valid CAS Registry Number.

100189-71-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name dec-9-enoxymethylbenzene

1.2 Other means of identification

Product number -
Other names Benzene,[(9-decenyloxy)methyl]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100189-71-7 SDS

100189-71-7Relevant academic research and scientific papers

CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF

-

Page/Page column 47-48; 69; 80, (2021/06/26)

The present application discloses a compound of formula (I) or a salt thereof: (I) and compositions comprising such compound or salt thereof. The use of such compound, salt thereof or composition comprising same for treating anemia or leukopenia, fibrosis, cancer, hypertension and/or a metabolic condition in a subject is also disclosed.

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

-

Paragraph 00243, (2018/10/19)

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

-

Paragraph 00617, (2017/04/11)

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

Enantioselective synthesis of (+)-patulolide C via proline-catalyzed sequential α-aminooxylation and Horner-Wadsworth-Emmons olefination

Sabitha, Gowravaram,Chandrashekhar,Yadagiri,Yadav

scheme or table, p. 3824 - 3826 (2010/08/19)

The enantioselective total synthesis of (+)-patulolide C isolated from Penicillium urticae has been achieved from commercially available 9-decen-1-ol. Jacobsen's kinetic resolution and sequential a-aminooxylation and Horner-Wadsworth-Emmons (HWE) olefinat

An efficient stereoselective synthesis of penaresidin A from (E)-2-protected amino-3,4-unsaturated sulfoxide

Raghavan, Sadagopan,Krishnaiah

supporting information; experimental part, p. 748 - 761 (2010/04/30)

(Chemical Equation Presented) An efficient, modular, asymmetric synthesis of penaresidin A is disclosed. A β-protected amino-γ, δ-unsaturated sulfoxide was prepared by stereoselective addition of the lithio anion of (R)-methyl p-tolyl sulfoxide to an unsa

An investigation of the influence of R on the abilities of the polar monomers CH2CH(CH2)8OR (R = Me, PhCH 2, Ph3C, Me3Si, Ph3Si) to participate in O- rather than η2-co

Stojcevic, Goran,Baird, Michael C.

experimental part, p. 8864 - 8877 (2010/02/16)

Copolymerization of ethylene and propylene with polar monomers of the types CH2CH(CH2)nOH (n = 1-12) in order to introduce polar functionality into the resulting polymers is possible in principle if the hydroxyl groups of

Vicinal diamination of terminal olefins

Pfaendler, Hans Rudolf,Klingl, Alexander

, p. 1486 - 1490 (2007/10/03)

The present publication describes an efficient and mild three-step conversion of a terminal olefin 1 into the corresponding 1,2-diamine 5. The sequence includes: azidoiodination, substitution with NaN3, and catalytic hydrogenolysis. The termina

Total Synthesis of (+)-Muconin

Yoshimitsu, Takehiko,Makino, Toshiyuki,Nagaoka, Hiroto

, p. 1993 - 1998 (2007/10/03)

(+)-Muconin (1), isolated from the leaves of Rollinia mucosa (Jacq.) Baill. (Annonaceae), is a sequential THF/THP-possessing acetogenin that exhibits potent and selective in vitro cytotoxicity toward pancreatic and breast tumor cell lines. In this study,

The first total synthesis of the marine fatty acid (±)-9-methoxypentadecanoic acid: A synthetic route towards mid-chain methoxylated fatty acids

Carballeira, Nestor M.,Miranda, Carlos

, p. 63 - 67 (2007/10/03)

The marine fatty acid (±)-9-methoxypentadecanoic acid was synthesized for the first time in seven steps (7.8% overall yield) starting from commercially available 9-decen-1-ol. The key step in the synthesis was the coupling of pentylmagnesium bromide with 1-benzyloxy-9,10-epoxydecane under 1,5-cyclooctadiene copper (I) chloride catalysis. Nuclear magnetic resonance data are provided for the first time for this type of methoxylated fatty acids and the synthetic approach utilized is of general applicability since it can be used in the synthesis of other mid-chain methoxylated fatty acids. This synthetic methodology should afford sufficient quantities of these fatty acids for biological evaluation. The spectral data obtained for the title compound will also be helpful in subsequent characterizations of other mid-chain methoxylated fatty acids using nuclear magnetic resonance spectroscopy.

Synthesis and Utilization of the Chiral Synthon Methyl 3-O-Benzyl-2,4,6-trideoxy-6-iodo-α-D-erythro-hexopyranoside in the Synthesis of a Potent HMG-CoA Reductase Inhibitor

Prugh, John D.,Rooney, C. Stanley,Deana, Albert A.,Ramjit, Harri G.

, p. 648 - 657 (2007/10/02)

Synthesis of the potent HMG-CoA reductase inhibitor 1a has been achieved by utilizing the chiral synthon 2, which was prepared from methyl α-D-glucopyranoside in 12 steps (6 new).A key step in this sequence, which should have general applicability for the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 100189-71-7